MX2022000047A - Sistema para proporcionar control de la natalidad. - Google Patents

Sistema para proporcionar control de la natalidad.

Info

Publication number
MX2022000047A
MX2022000047A MX2022000047A MX2022000047A MX2022000047A MX 2022000047 A MX2022000047 A MX 2022000047A MX 2022000047 A MX2022000047 A MX 2022000047A MX 2022000047 A MX2022000047 A MX 2022000047A MX 2022000047 A MX2022000047 A MX 2022000047A
Authority
MX
Mexico
Prior art keywords
birth control
providing
providing birth
thirteen
comprised
Prior art date
Application number
MX2022000047A
Other languages
English (en)
Inventor
Bruce Variano
Original Assignee
The Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Population Council Inc filed Critical The Population Council Inc
Publication of MX2022000047A publication Critical patent/MX2022000047A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente descripción se relaciona con un sistema vaginal que previene el embarazo comprendido por acetato de segesterona y etinilestradiol y está configurado para trece ciclos de uso de producto de 28 días.
MX2022000047A 2019-06-21 2020-06-19 Sistema para proporcionar control de la natalidad. MX2022000047A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/448,399 US10918649B2 (en) 2019-06-21 2019-06-21 System for providing birth control
PCT/US2020/038568 WO2020257544A1 (en) 2019-06-21 2020-06-19 System for providing birth control

Publications (1)

Publication Number Publication Date
MX2022000047A true MX2022000047A (es) 2022-04-06

Family

ID=71528001

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022000047A MX2022000047A (es) 2019-06-21 2020-06-19 Sistema para proporcionar control de la natalidad.

Country Status (15)

Country Link
US (5) US10918649B2 (es)
EP (1) EP3986375A1 (es)
JP (1) JP2022536836A (es)
KR (1) KR20220027979A (es)
CN (1) CN114364369A (es)
AR (1) AR120976A1 (es)
AU (1) AU2020294780A1 (es)
BR (1) BR112021025853A2 (es)
CA (1) CA3141077A1 (es)
CL (1) CL2021003410A1 (es)
CO (1) CO2021017509A2 (es)
IL (1) IL289135A (es)
MX (1) MX2022000047A (es)
WO (1) WO2020257544A1 (es)
ZA (1) ZA202110288B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
US11529308B2 (en) * 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2616064A1 (de) 1976-04-09 1977-10-20 Schering Ag Vaginalring iii
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
TW358031B (en) 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
HUP0004967A2 (en) 2000-12-18 2002-09-28 Richter Gedeon Vegyeszet New crystalline form of nestorone and process for the preparation thereof
EP2170276B1 (en) 2007-06-26 2018-08-22 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
DK2359807T3 (en) 2008-02-04 2017-10-16 Ferring Bv Monolithic vaginal rings comprising progesterone and methods of preparation and use thereof
DE102010003494A1 (de) 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
US8580294B2 (en) * 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CN103619914B (zh) * 2011-05-30 2016-09-07 道康宁东丽株式会社 有机聚硅氧烷弹性体及其运用
JP2013011233A (ja) 2011-06-29 2013-01-17 Mitsubishi Heavy Ind Ltd 風力発電装置保守装置および風力発電装置保守方法
CN107955052A (zh) 2011-12-23 2018-04-24 晶体制药独资有限公司 炔基化16-取代-17-酮基类固醇的方法
CN104271084B (zh) * 2011-12-29 2017-03-01 智利大学 包含dhea或硫酸dhea和任选地包含调节该活性成分的释放的试剂的阴道环
EP2800775B1 (en) * 2012-01-04 2018-04-18 Momentive Performance Materials Inc. Curable compositions of ionic silicones
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
EP3209251A4 (en) 2014-10-22 2018-03-28 International Partnership for Microbicides, Inc. Platinum-catalyzed silicone drug delivery devices and methods of use thereof
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US11529308B2 (en) 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control

Also Published As

Publication number Publication date
US20200397800A1 (en) 2020-12-24
US20220054503A1 (en) 2022-02-24
CA3141077A1 (en) 2020-12-24
AU2020294780A1 (en) 2022-01-27
ZA202110288B (en) 2023-10-25
US20210290637A1 (en) 2021-09-23
CL2021003410A1 (es) 2022-10-07
US20200397801A1 (en) 2020-12-24
CO2021017509A2 (es) 2022-04-19
IL289135A (en) 2022-02-01
US10940157B2 (en) 2021-03-09
WO2020257544A1 (en) 2020-12-24
AR120976A1 (es) 2022-04-06
US10925882B2 (en) 2021-02-23
US10918649B2 (en) 2021-02-16
KR20220027979A (ko) 2022-03-08
US20200397802A1 (en) 2020-12-24
BR112021025853A2 (pt) 2022-03-03
JP2022536836A (ja) 2022-08-19
US11850251B2 (en) 2023-12-26
CN114364369A (zh) 2022-04-15
EP3986375A1 (en) 2022-04-27

Similar Documents

Publication Publication Date Title
ZA202110288B (en) System for providing birth control
MX2022012917A (es) Composiciones anticonceptivas con efectos adversos reducidos.
MY181349A (en) Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
PH12021550862A1 (en) Catamenial fluid removal
EP3995091A4 (en) DIRECT VISION ABORTION UTERINE CURETAGE DEVICE AND SYSTEM
MX2022006073A (es) Metodos para utilizar anticuerpos anti-trem2.
CR20210143A (es) Utilización de un inhibidor de catepsina s contra la formación de anticuerpos anti-fármaco
BR112015023381A2 (pt) composição de liberação imediata de sovaprevir, composição de sovaprevir de 200 mg, núcleo de comprimido de sovaprevir e comprimido de sovaprevir revestido
MX2015012996A (es) Uso de sistemas de carbohidrato especificos durante el embarazo, para prevenir la acumulacion de grasa en mujeres embarazadas.
MX2020006344A (es) Uso de celiprolol para tratar el sindrome de ehlers-danlos vascular en mujeres durante el embarazo y el periodo periparto.
Dávila et al. Dual Protection Contraception Among South African Women
PH12015502132A1 (en) Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring
IES87158Y1 (en) A bib system
Vetrova et al. OSOBENNOSTI ANAMNEZA, TEChENIYa BEREMENNOSTI I RODOV PRI MALOVODII
Greenblatt et al. Estradiol pellet implantation for contraception
UA143536U (uk) Спосіб лікування загрози передчасних пологів
MX2022002063A (es) Mioinositol y la prevencion de pprom.
BR112019004482A2 (pt) dispositivo e sistema ortodônticos
Warboys Breastfeeding as birth control
ES39292U (es) Nuevo dispositivo de ligadura
MX2018008665A (es) Pomada antiestrias.
ES2722698A1 (es) Sistema de anclaje dental para la fijacion de protesis
UA126990U (uk) В'яжуче
AU149217B2 (en) Hydraulic system and multipurpose control valve
CA465556A (en) Brake cylinder release valve with retainer control